Short answer: Ginger (Zingiber officinale) is the underground rhizome of a perennial herb in the Zingiberaceae family, native to maritime Southeast Asia and cultivated globally for culinary, medicinal, and supplemental use. Per standard botanical references, ginger contains a complex mixture of phenolic compounds including gingerols (6-gingerol, 8-gingerol, 10-gingerol — the fresh-rhizome dominant phenolics), shogaols (6-shogaol, 8-shogaol, 10-shogaol — produced by dehydration of gingerols during drying and heating, dominant in dried ginger), and volatile terpenoids that produce the characteristic aroma. Per Holtmann 2009 (Aliment Pharmacol Ther) human ginger nausea review and Marx 2013 (Br J Nutr) gingerol mechanistic work, gingerols and shogaols exhibit 5-hydroxytryptamine receptor type 3 (5-HT3) antagonist activity in vitro and in human pharmacological studies, similar in mechanism to the prescription anti-emetic ondansetron. Per Akhtar 2017 (Vet World) ginger veterinary applications review, canine and feline evidence for ginger anti-emetic effect is modest — some clinical reports support palliative use for motion-sickness vomiting and chemotherapy-induced nausea, but the evidence base is substantially smaller than the human literature. Per AAFCO 2024 Official Publication ingredient definition and FDA-CVM, ginger is an accepted pet food ingredient. Pet food inclusion is typically 0.05–0.2 percent of finished product weight, well below human therapeutic dose (typically 1–4 grams ground ginger per day for anti-emetic palliation). The KibbleIQ rubric treats ginger as a neutral marketing botanical signal — functional claim plausible in principle but sub-therapeutic at commercial inclusion. The 2010–2024 industry commentary on ginger in pet food is covered on our ginger pet food inclusion overview.

Botanical identity and source

Per standard botanical and crop production references, Zingiber officinale is a perennial herb in the Zingiberaceae (ginger) family, native to maritime Southeast Asia (the area encompassing modern Indonesia, Malaysia, and India) and now cultivated globally in tropical and sub-tropical climates. Per FAO 2023 (State of World Agriculture) crop production data, leading producers include India (40–50 percent of global supply), Nigeria, China, Indonesia, and Nepal. Global ginger production exceeds 4 million tonnes annually.

The harvested edible portion is the rhizome — the horizontal underground stem that stores starch and the characteristic phenolic compounds for the plant’s growth cycle. Fresh ginger rhizome is approximately 80 percent water, 16 percent starch, 2 percent protein, and 0.5 percent essential oils plus phenolic compounds. Dried ginger powder is the form used in pet food and most human supplemental applications, produced by slicing the fresh rhizome and drying at 50–60°C to under 10 percent moisture, then grinding to powder. Per AAFCO 2024 ingredient definition, both fresh and dried ginger are accepted pet food ingredients. The botanical framework overlaps with our turmeric explainer, which covers another rhizomatous Zingiberaceae family member (Curcuma longa).

Gingerol and shogaol pharmacology

Per Marx 2013 (Br J Nutr) gingerol mechanistic review and Mansingh 2007 (Phytochemistry) ginger phenolic chemistry work, ginger’s pharmacologically active compounds are the gingerol and shogaol families of phenolic ketones. Fresh ginger rhizome is dominated by 6-gingerol, 8-gingerol, and 10-gingerol; dried and heated ginger is dominated by the corresponding shogaols, which are produced by dehydration of the gingerol beta-hydroxyl group during drying and heating. The shogaols are typically more bioactive than the parent gingerols per Pan 2008 (Mol Nutr Food Res) gingerol vs shogaol comparative work.

Per Holtmann 2009 (Aliment Pharmacol Ther) human ginger nausea review and Walstab 2013 (Neurogastroenterol Motil) 5-HT3 antagonism work, gingerols and shogaols exhibit 5-hydroxytryptamine receptor type 3 (5-HT3) antagonist activity in vitro and in human pharmacological studies. The 5-HT3 receptor is the molecular target of prescription anti-emetic drugs (ondansetron, granisetron) widely used in human medicine for chemotherapy-induced and post-operative nausea. Ginger’s 5-HT3 antagonism is substantially weaker than the prescription drugs but operates through the same mechanism. The receptor framework overlaps with discussion of CB1, CB2, and 5-HT3 receptor pharmacology in human and veterinary medicine.

Anti-emetic evidence in humans vs companion animals

The human evidence base for ginger anti-emetic palliation is substantial. Per Lete 2016 (Integr Med Insights) meta-analysis of ginger for pregnancy-induced nausea, ginger at 1–1.5 grams per day reduces nausea symptoms with modest effect size and good safety profile. Per Marx 2017 (Crit Rev Food Sci) ginger and chemotherapy-induced nausea review, ginger at 1–4 grams per day reduces post-chemotherapy nausea in some patient populations. Per Ernst 2000 (Br J Anaesth) post-operative nausea systematic review, ginger reduces post-operative nausea modestly. Per Lien 2003 (Am J Physiol) motion sickness work, ginger reduces motion sickness symptoms.

The canine and feline evidence base is substantially smaller. Per Akhtar 2017 (Vet World) ginger veterinary applications review, ginger is occasionally used clinically for motion-sickness palliation in dogs traveling by car or boat, with anecdotal but not randomized-trial evidence supporting use. Some integrative-medicine veterinarians use ginger for chemotherapy-induced nausea in oncology patients. Per AAHA 2022 GI consensus framework, ginger is not first-line therapy for canine or feline nausea — standard anti-emetic prescriptions (maropitant, ondansetron, metoclopramide) have substantially better evidence and effect size in companion animal medicine. The veterinary framework overlaps with our best dog food for sensitive stomachs guide.

Pet food inclusion rate and sub-therapeutic dose framework

Per standard pet food formulation references and AAFCO 2024 Official Publication, ginger in commercial pet food is typically included at 0.05–0.2 percent of finished product weight — below the apparent threshold of palatability impact (ginger has a strong pungent flavor at higher inclusion) and well below human therapeutic dose. For a 20 kg dog consuming approximately 300 g of dry food per day, this delivers approximately 0.15–0.6 grams of ginger powder per day — a fraction of the 1–4 gram human therapeutic dose scaled by body weight.

The sub-therapeutic inclusion means that ginger in commercial pet food functions primarily as a marketing botanical (consumer-facing "natural ingredient" or "digestive support" positioning) and possibly a minor palatant rather than a meaningful anti-emetic intervention. Pet owners seeking ginger’s anti-emetic palliation for motion-sickness or chemotherapy-induced nausea should typically supplement with dedicated ginger capsules or fresh ginger at therapeutic doses, discussed with their veterinarian, rather than relying on commercial pet food inclusion. The marketing-botanical framework overlaps with our turmeric explainer (curcumin marketing claims) and rosemary extract explainer (carnosic acid functional claims).

How KibbleIQ scores ginger

The KibbleIQ Dry Kibble Rubric treats ginger as a neutral marketing botanical signal. Ginger in commercial pet food at typical inclusion of 0.05–0.2 percent is below the threshold of clinical anti-emetic effect, making the "digestive support" or "anti-nausea" marketing claims functionally aspirational rather than evidence-supported. The rubric does not award credit for ginger as a "natural" or "superfood" ingredient beyond its sensory contribution. The rubric does not penalize ginger either — the ingredient is safe at typical pet food inclusion and may contribute modestly to palatability.

To check the botanical and supplemental ingredient profile of your dog’s food, paste the ingredient list into the KibbleIQ analyzer. For peer botanical context, see our turmeric explainer, rosemary extract explainer, green tea extract explainer, yucca schidigera explainer, and milk thistle explainer. For digestive-support context, see best dog food for sensitive stomachs and our pumpkin explainer. For methodology context, see our published methodology.